After 14 reported cases, Health Canada is warning that glatiramer acetate products for MS can cause anaphylaxis, a severe allergic reaction.

A study identified a protein that stalls myelin repair in the brain, suggesting that targeting it could be a strategy for MS treatment.

Columnist Leigh Anne Nelson describes the odd itching sensation she experiences due to MS, which occurs randomly and suddenly.

Civicascript said its low-cost generic version of Ampyra is now available in the U.S., offering significant savings and ...

A new artificial intelligence model suggests that MS should be classified along a single disease continuum rather than into ...

The UAE became the first country to approve tolebrutinib, making it available to adults with nonrelapsing secondary progressive MS.

Columnist Ben Hofmeister knows what it's like to grieve his multiple sclerosis and has learned what well-meaning words not to say.